Incorrect username and/or password, please try again or click to reset.

Sign up for your ticket to see PharmData at the Pharmacy Show for a chance to win a £100 Amazon voucher!

Class 2 Medicines Recall: Hikma Pharmaceuticals USA Inc, Lorazepam 2mg/ml Injection, Lorazepam 4mg/ml Injection (unlicensed medicines), EL(22)A/37

2022-08-30 10:00:10 (2 year(s) ago)

Summary

Hikma Pharmaceuticals USA Inc are recalling the below batches due to an out of specification result with related substances during testing for retain samples.

Read full MHRA article

Respond to this alert